Effects of levosimendan and dobutamine on experimental acute lung injury in rats

Acta Histochemica

Volumn 111, Issue 5, 2009, Pages 404-414

  Erbüyün, Koray ^a   Vatansever, Seda ^a   Tok, Demet ^a   Ok, Gülay ^a   Türköz, Ergin ^a   Aydede, Hasan ^a   Erhan, Yamaç ^a   Tekin, Idil ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

Author keywords

Dobutamine; Levosimendan; Lung injury; Rats; Sepsis

Indexed keywords

DOBUTAMINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LEVOSIMENDAN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EXPERIMENTAL STUDY; HISTOPATHOLOGY; IMMUNOREACTIVITY; MALE; NICK END LABELING; NONHUMAN; PERITONITIS; RAT;

ACUTE LUNG INJURY; ANIMALS; CARDIOTONIC AGENTS; DOBUTAMINE; HYDRAZONES; HYPERTENSION; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INTERLEUKIN-1BETA; LUNG; MALE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PYRIDAZINES; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS; RATTUS NORVEGICUS;

EID: 67349244330     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2008.09.010     Document Type: Article

References (39)

1. Behrends M., and Peters J. The calcium sensitizer levosimendan attenuates endotoxin-evoked myocardial dysfunction in isolated guinea pig hearts. Intensive Care Med 29 (2003) 1802-1807
2. Bhatia M., and Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 202 (2004) 145-156
3. Buwalda M., and Ince C. Opening the microcirculation: can vasodilators be useful in sepsis?. Intensive Care Med 28 (2002) 1208-1217
4. Dellinger R.P., Levy M.M., Carlet J.M., Bion J., Parker M.M., Jaeschke R., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 34 (2008) 17-60
5. Dubin A., Maskin B., Murias G., Pozo M.O., Sottile J.P., Baran M., et al. Effects of levosimendan in normodynamic endotoxaemia: a controlled experimental study. Resuscitation 69 (2006) 277-286
6. Dubin A., Murias G., Sottile J.P., Pozo M.O., Baran M., Edul V.S.K., et al. Effects of levosimendan and dobutamine in experimental acute endotoxemia: a preliminary controlled study. Intensive Care Med 33 (2007) 485-494
7. Duranteau J., Sitbon P., Teboul J.L., Vicaut E., Anguel N., Richard C., et al. Effects of epinephrine, norepinephrine or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock. Crit Care Med 27 (1999) 893-900
8. Faivre V., Kaskos H., Callebert J., Losser M.R., Milliez P., Bonnin P., et al. Cardiac and renal effects of levosimendan, arginine vasopressin, and norepinephrine in lipopolysaccharide-treated rabbits. Anesthesiology 103 (2005) 514-521
9. Fiddian-Green R.G., Haglund U., Gutierrez G., and Shoemaker W.C. Goals for the resuscitation of shock. Crit Care Med 21 2 Suppl (1993) S25-S31
10. Fink M.P., and Heard S.O. Laboratory models of sepsis and septic shock. J Surg Res 49 (1990) 186-196
11. Ghosh S., Latimer R.D., Gray B.M., Harwood R.J., and Oduro A. Endotoxin-induced organ injury. Crit Care Med 21 2 Suppl (1993) S19-S24
12. Hiltebrand L.B., Krejci V., and Sigurdsson G.H. Effects of dopamine, dobutamine, and dopexamine on microcirculatory blood flow in the gastrointestinal tract during sepsis and anesthesia. Anesthesiology 100 (2004) 1188-1197
13. Hobson K.G., Young K.M., Ciraulo A., Palmieri T.L., and Greenhalgh D.G. Release of abdominal compartment syndrome improves survival in patients with burn injury. J Trauma 53 (2002) 1129-1133
14. Lebuffe G., Levy B., Neviere R., Chagnon J.L., Perrigault P.F., Duranteau J., et al. Dobutamine and gastric-to-arterial carbon dioxide gap in severe sepsis without shock. Intensive Care Med 28 (2002) 265-271
15. Lisbon A. Dopexamine, dobutamine, and dopamine increase splanchnic blood flow: what is the evidence?. Chest 123 5 Suppl (2003) 460S-463S
16. Marik P., and Mohedin M. The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 272 (1994) 1354-1357
17. Matejovic M., Krouzecky A., Martinkova V., Rokyta Jr. R., Kralova H., Treska V., et al. Selective inducible nitric oxide synthase inhibition during long-term hyperdynamic porcine bacteremia. Shock 21 (2004) 458-465
18. Matejovic M., Krouzecky A., Martinkova V., Rokyta Jr. R., Radej J., Kralova H., et al. Effects of tempol, a free radical scavenger, on long-term hyperdynamic porcine bacteremia. Crit Care Med 33 (2005) 1057-1063
19. McDonald T.E., Grinman M.N., Carthy C.M., and Walley K.R. Endotoxin infusion in rats induces apoptotic and survival pathways in hearts. Am J Physiol Heart Circ Physiol 279 (2000) H2053-H2061
20. McLean A.S., Huang D.S.J., Stewart D.E., Nalos M., and Tang B. Efficacy of levosimendan in shock. Crit Care Med Suppl 1 (2004) 83 [abstract]
21. Morelli A., De Castro S., Teboul J.L., Singer M., Rocco M., Conti G., et al. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med 31 (2005) 638-644
22. Neviere R., Mathieu D., Chagnon J.L., Lebleu N., and Wattel F. The contrasting effects of dobutamine and dopamine on gastric mucosal perfusion in septic patients. Am J Respir Crit Care Med 154 (1996) 1684-1688
23. Noto A., Giacomini M., Palandi A., Stabile L., Reali-Forster C., and Iapichino G. Levosimendan in septic cardiac failure. Intensive Care Med 31 (2005) 164-165
24. Oda J., Ivatury R.R., Blocher C.R., Malhotra A.J., and Sugerman H.J. Amplified cytokine response and lung injury by sequential hemorrhagic shock and abdominal compartment syndrome in a laboratory model of ischemia-reperfusion. J Trauma 52 (2002) 625-631
25. Oda J., Ueyama M., Yamashita K., Inoue T., Harunari N., Ode Y., et al. Effects of escharatomy as abdominal decompression on cardiopulmonary function and visceral perfusion in abdominal compartment syndrome with burn patients. J Trauma 59 (2005) 369-374
26. Oldner A., Konrad D., Weitzberg E., Rudehill A., Rossi P., and Wanecek M. Effects of levosimendan, a novel inotropic calcium sensitizing drug, in experimental septic shock. Crit Care Med 29 (2001) 2185-2193
27. Pagel P.S., Hettrick D.A., and Warltier D.C. Influence of levosimendan, pimobendan, and milrinone on the regional distribution of cardiac output in anaesthetized dogs. Br J Pharmacol 119 (1996) 609-615
28. Parker M.M., Shelhamer J.H., Natanson C., Alling D.W., and Parrillo J.E. Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. Crit Care Med 15 (1987) 923-929
29. Pittner A., Nalos M., Asfar P., Yang Y., Ince C., Georgieff M., et al. Mechanisms of inducible nitric oxide synthase (iNOS) inhibition-related improvement of gut mucosal acidosis during hyperdynamic porcine endotoxemia. Intensive Care Med 29 (2003) 312-316
30. Rezende-Neto J.B., Moore E.E., Melo de Andrade M.V., Teixeira M.M., Lisboa F.A., Arantes R.M., et al. Systemic inflammatory response secondary to abdominal compartment syndrome: stage for multiple organ failure. J Trauma 53 (2002) 1121-1128
31. Rezende-Neto J.B., Moore E.E., Masuno T., Moore P.K., Johnson J.L., Sheppard F.R., et al. The abdominal compartment syndrome as a second insult during systemic neutrophil priming provokes multiple organ injury. Shock 20 (2003) 303-308
32. Schlichting D., and McCollam J.S. Recognizing and managing severe sepsis: a common and deadly threat. South Med J 100 (2007) 594-600
33. 2 balance during endotoxemia in pigs. Intensive Care Med 31 (2005) 985-992
34. Sielenkamper A.W., Chin-Yee I.H., Martin C.M., and Sibbald W.J. Diaspirin crosslinked hemoglobin improves systemic oxygen uptake in oxygen supply-dependent septic rats. Am J Respir Crit Care Med 156 (1997) 1066-1072
35. Silva E., DeBacker D., Créteur J., and Vincent J.L. Effects of vasoactive drugs on gastric intramucosal pH. Crit Care Med 26 (1998) 1749-1758
36. Wang P., Yoo P., Zhou M., Cioffi W.G., Ba Z.F., and Chaudry I.H. Reduction in vascular responsiveness to adrenomedullin during sepsis. J Surg Res 85 (1999) 59-65
37. Wichterman K.A., Baue A.E., and Chaudry I.H. Sepsis and septic shock-a review of laboratory models and a proposal. J Surg Res 29 (1980) 189-201
38. Wind J., Versteegt J., Twisk J., van der Werf T.S., Bindels A.J., Spijkstra J.J., et al. Epidemiology of acute lung injury and acute respiratory distress syndrome in The Netherlands: a survey. Respir Med 101 (2007) 2091-2098
39. + channel in rat arterial myocytes. Eur J Pharmacol 333 (1997) 249-259